Concord Drugs BSE
33.05 00.00 (1.04%) 
To view real-time data of Concord Drugs and trade with industry first features, Login or Open Free Demat Account.
Company Fundamentals
Company Valuation
| Market Cap (Rs Cr.) | 27.80 |
| Book Value (Rs) | 34.97 |
| Face Value (Rs) | 10.00 |
| P/E ratio | 23.38 |
| Dividend Yield | 0.0 % |
Ownership & Shareholding
Company Ownership
Shareholding Pattern
| Held by | Jun-2023 | Mar-2023 | Mar-2023 | Dec-2022 | Sept-2022 |
| Promoters | 52.13 % | 52.13 % | 52.13 % | 49.00 % | 49.00 % |
| Non-Promoters | 0.04 % | 0.03 % | 0.02 % | 0.02 % | 0.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Domestic Instituitions | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Foreign Instituitions | 0.24 % | 0.25 % | 0.25 % | 0.26 % | 0.28 % |
| Others | 47.59 % | 47.60 % | 47.60 % | 50.72 % | 50.68 % |
Sector
| Sector | Pharmaceuticals |
| Sub Sector | Pharmaceuticals & Drugs |
| Company Classification | Smallcap |
Exchange Scrips
| BSE | sec_id |
| NSE | sec_id |
| ISIN | INE858L01010 |
Stock Part of Following Indices
| Name | Current Value | Change |
Frequently Asked Questions on Concord Drugs Share
Concord Drugs share has a market capitalization of 27.80 as of today. The share is trading at and has moved by -1.58% in the last year, 49.25% in the last 3 years, and 38.52% in the last 5 years.
Concord Drugs has a P/E ratio of 23.38 as of today. You can check the latest P/E ratio of Concord Drugs and all other listed stocks on Dhan. Open a demat account now!
The ownership stake of Concord Drugs is split as follows:
- DIIs:
- FIIs:
- Promoters:
- Non-Promoters:
Make informed investing decisions by viewing shareholding patterns on Dhan Stock Trading App or Web Trading Platform Now!
You can use the Dhan App or Web to start fundamental analysis and invest in Concord Drugs share. Begin with free demat account opening and then add money. Search for a stock that you want to analyze, like Concord Drugs. Tap on the “Fundamentals” tab and view all pertinent information in one place.
Concord Drugs Fundamental Analysis Overview
Concord Drugs Fundamental Analysis offers an overview of the company's Market Capitalization, Book Value, P/E Ratio, Dividend Yield and more. It helps to analyse the company's fundamental position and its current shareholding pattern and historical shareholding movement. Presently, the current market cap of Concord Drugs is Rs. 27.80. The Face Value and Book Value per share are Rs. 10.00 and Rs. 34.97 respectively. Current P/E ratio of Concord Drugs stands at 23.38. The promoters holding in the company stands at , while Domestic Institutions stand at 00.00% and Foreign Institutions hold 00.00. While understanding and analysing Fundamentals of a company is very crucial, it is equally important to look at the Share Price, Stock Performance, Financial Statements, Technical Analysis and Similar Stocks Comparision. It gives a sense of whether the company is growing, stable or deteriorating.
